Anthony Mikulec, MD
Otology & Neurotology · St. Louis, MONPI 1104843176
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,742 of the $3,028 with a category attached, or 90.5%. Otonomy, Inc. accounts for 90.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $2,217 and has fallen 95.8% since, to $94 in 2025.
Across 8 payments — averaging $378.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otonomy, Inc.$3K
- Intersect ENT, Inc.$148
- Regeneron Healthcare Solutions, Inc.$94
- Johnson & Johnson$24
- Optinose US, Inc.$20
Across 9 payments — averaging $3422.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otonomy, Inc.$31K
What the payments were for
- Consulting fees$2,74291%
- Food & beverage$2879%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otonomy, Inc. | 4 | $2,742 |
| Intersect ENT, Inc. | 1 | $148 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| Johnson & Johnson | 1 | $24 |
| Optinose US, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few otology & neurotology providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 16 | $1,801 |
| Diazepam | 79 | $427 |
| Ofloxacin | 11 | $148 |
Paid to pharmacies, not to this prescriber.
Other otology & neurotology in St. Louis
- Jacques HerzogSaint Louis$62K
- Nedim DurakovicCreve Coeur$26K
- Matthew ShewSaint Louis$9K
- Pawina JiramongkolchaiSaint Louis$3K
- James BeneckeSaint Louis$2K
- Arnaldo Rivera PerezColumbia$2K
- Mark van EssSpringfield$948
- Bradley ThedingerKansas City$585
- Peter SmithSaint Louis$150
- Richard CholeSaint Louis$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.